Literature DB >> 17761366

Inflammatory proteins on HDL: what are we measuring?

Kevin D O'Brien.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17761366      PMCID: PMC3380078          DOI: 10.1016/j.trsl.2007.04.007

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


× No keyword cloud information.
  25 in total

1.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Authors:  Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

2.  Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes.

Authors:  M A Deeg; R F Bowen; M D Williams; L K Olson; E A Kirk; R C LeBoeuf
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-07       Impact factor: 4.310

3.  An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study.

Authors:  Aaron R Folsom; Lloyd E Chambless; Christie M Ballantyne; Josef Coresh; Gerardo Heiss; Kenneth K Wu; Eric Boerwinkle; Thomas H Mosley; Paul Sorlie; Guoqing Diao; A Richey Sharrett
Journal:  Arch Intern Med       Date:  2006-07-10

4.  Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease.

Authors:  S Pennathur; V Jackson-Lewis; S Przedborski; J W Heinecke
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

5.  High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.

Authors:  Michael Miller; Min Zhan; Stephen Havas
Journal:  Arch Intern Med       Date:  2005-10-10

6.  Glycosylphosphatidylinositol-specific phospholipase D is expressed by macrophages in human atherosclerosis and colocalizes with oxidation epitopes.

Authors:  K D O'Brien; C Pineda; W S Chiu; R Bowen; M A Deeg
Journal:  Circulation       Date:  1999-06-08       Impact factor: 29.690

7.  Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.

Authors:  Baohai Shao; Xiaoyun Fu; Thomas O McDonald; Pattie S Green; Koji Uchida; Kevin D O'Brien; John F Oram; Jay W Heinecke
Journal:  J Biol Chem       Date:  2005-08-25       Impact factor: 5.157

8.  Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.

Authors:  Kevin D O'Brien; Thomas O McDonald; Vidya Kunjathoor; KimLi Eng; Eleanor A Knopp; Katherine Lewis; Roland Lopez; Elizabeth A Kirk; Alan Chait; Thomas N Wight; Frederick C deBeer; Renee C LeBoeuf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-03       Impact factor: 8.311

9.  Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins.

Authors:  K D O'Brien; K L Olin; C E Alpers; W Chiu; M Ferguson; K Hudkins; T N Wight; A Chait
Journal:  Circulation       Date:  1998-08-11       Impact factor: 29.690

10.  Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway.

Authors:  S D Tachado; P Gerold; M J McConville; T Baldwin; D Quilici; R T Schwarz; L Schofield
Journal:  J Immunol       Date:  1996-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.